Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nand

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Neurotoxicity associated with systemic high-dose cytosine arabinosideS Nand, H L Messmore, R Patel, et al.
Leukemia|March 1, 1992
Phase II trial of recombinant human interferon alpha in myelodysplastic syndromesS Nand, T Ellis, H Messmore, et al.
American Journal of Hematology|May 1, 1990
Leukemic transformation in polycythemia vera: analysis of risk factorsS Nand, H Messmore, S G Fisher, et al.
Archives of Internal Medicine|August 1, 1985
Red cell fragmentation syndrome with the use of subclavian hemodialysis cathetersS Nand, V K Bansal, G Kozeny, et al.
Journal of Viral Hepatitis|July 3, 2004
Lymphoproliferative disorders in chronic hepatitis CR Idilman, A Colantoni, N De Maria, et al.
Leukemia Research|September 4, 1999
A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group StudyC Karanes, K J Kopecky, D R Head, et al.
Leukemia|October 18, 2016
Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathwayJ Xin, D You, P Breslin, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Neurotoxicity associated with systemic high-dose cytosine arabinosideS Nand, H L Messmore, R Patel, et al.
Leukemia|March 1, 1992
Phase II trial of recombinant human interferon alpha in myelodysplastic syndromesS Nand, T Ellis, H Messmore, et al.
American Journal of Hematology|May 1, 1990
Leukemic transformation in polycythemia vera: analysis of risk factorsS Nand, H Messmore, S G Fisher, et al.
Archives of Internal Medicine|August 1, 1985
Red cell fragmentation syndrome with the use of subclavian hemodialysis cathetersS Nand, V K Bansal, G Kozeny, et al.
Journal of Viral Hepatitis|July 3, 2004
Lymphoproliferative disorders in chronic hepatitis CR Idilman, A Colantoni, N De Maria, et al.
Leukemia Research|September 4, 1999
A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group StudyC Karanes, K J Kopecky, D R Head, et al.
Leukemia|October 18, 2016
Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathwayJ Xin, D You, P Breslin, et al.
Pageof 5